3.24
-0.05 (-1.52%)
-0.05 (-1.52%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CTI BioPharma Corporation | CTIC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.05 | -1.52% | 3.24 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.28 | 3.23 | 3.39 | 3.24 | 3.29 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.26 | 3.36 | 0.10 | 1 | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,999 | 362,844 | $ 3.30 | $ 1,197,284 | 504,594 | 0.62 - 4.0322 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:56:56 | 49 | $ 3.27 | USD |
CTI BioPharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 244.53M | 75.47M | 58.83M | $ 3.35M | $ - | -0.69 | -4.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
CTI BioPharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTIC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.50 | 3.54 | 3.23 | 3.37 | 329,249 | -0.26 | -7.43% |
| 1 Month | 3.63 | 3.64 | 3.17 | 3.39 | 406,539 | -0.39 | -10.74% |
| 3 Months | 3.40 | 4.0322 | 3.02 | 3.43 | 595,777 | -0.16 | -4.71% |
| 6 Months | 1.25 | 4.0322 | 0.9629 | 2.56 | 2,218,837 | 1.99 | 159.2% |
| 1 Year | 1.35 | 4.0322 | 0.62 | 2.37 | 1,309,417 | 1.89 | 140.0% |
| 3 Years | 3.48 | 5.3601 | 0.6001 | 2.33 | 673,937 | -0.24 | -6.9% |
| 5 Years | 11.60 | 13.00 | 0.6001 | 3.33 | 672,906 | -8.36 | -72.07% |
CTI BioPharma Description
| CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. The company's therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis. |
